Advising ABLE Human Motion, a start-up that designed a robotic exoskeleton that improves the mobility of individuals with disabilities

In June 2019, also advised by the firm, the start-up closed its first investment round and, between late 2022 and early 2023, carried out a subscription of a series of convertible notes that have now been capitalised.

ABLE Human Motion designed the world's lightest, fastest to put on, and most cost-effective exoskeleton for neurorehabilitation. The device intended for clinical use has received European certification after being successfully tested in leading neurological rehabilitation hospitals in Spain and Germany and will be available as of July.

The team led by Ramon Manyà and Ismael Peralta, Associates of the Innovation and Entrepreneurship Area, advised the company.